Literature DB >> 15803440

A method to estimate the variance of an endpoint from an on-going blinded trial.

Biao Xing1, Jitendra Ganju.   

Abstract

Blinded estimation of variance allows for changing the sample size without compromising the integrity of the trial. Some of the methods that estimate the variance in a blinded manner either make untenable assumptions or are only applicable to two-treatment trials. We propose a new method for continuous endpoints that makes minimal assumptions. The method uses the enrollment order of subjects and the randomization block size to estimate the variance. It can be applied to normal or non-normal data, trials with two or more treatments, equal or unequal allocation schemes, fixed or random randomization block sizes, and single or multi-centre trials. The variance estimator is unbiased and performs best when the randomization block size is the smallest. Simulation results suggest that for many commonly used randomization block sizes the proposed estimator is expected to perform well. The proposed method is used to estimate the variance of the endpoint for two trials and is shown to perform well by comparison with its unblinded counterpart. Copyright 2005 John Wiley & Sons, Ltd.

Mesh:

Year:  2005        PMID: 15803440     DOI: 10.1002/sim.2070

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  EM Estimation for Finite Mixture Models with Known Mixture Component Size.

Authors:  Chen Teel; Taeyoung Park; Allan R Sampson
Journal:  Commun Stat Simul Comput       Date:  2015-07       Impact factor: 1.118

2.  Unplanned adaptations before breaking the blind.

Authors:  Martin Posch; Michael A Proschan
Journal:  Stat Med       Date:  2012-06-27       Impact factor: 2.373

3.  Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations.

Authors:  Cornelia U Kunz; Nigel Stallard; Nicholas Parsons; Susan Todd; Tim Friede
Journal:  Biom J       Date:  2016-11-25       Impact factor: 2.207

4.  Blinded and unblinded sample size reestimation in crossover trials balanced for period.

Authors:  Michael J Grayling; Adrian P Mander; James M S Wason
Journal:  Biom J       Date:  2018-08-03       Impact factor: 2.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.